Safety and pharmacokinetics of rituximab in combination with FAB chemotherapy in children and adolescents with Stage III/IV mature B-NHL and B-cell leukemia ± CNS disease: a Children's Oncology Group Report

被引：0
|
作者：
Barth, M. J. [1 ]
Goldman, S. [2 ]
Zhi, J. [3 ]
Smith, L. [4 ]
Harrison, L. [5 ]
Perkins, S. L. [6 ]
Shiramizu, B. [7 ]
Gross, T. [6 ,8 ]
Sanger, W. [4 ]
Cairo, M. S. [5 ,9 ,10 ,11 ,12 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] Med City Childrens Hosp, Div Pediat Hematol Oncol, Dallas, TX USA
[3] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
[4] Univ Nebraska, Coll Publ Hlth, Dept Biostat, Omaha, NE 68182 USA
[5] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA
[6] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[7] Univ Hawaii, Div Pediat Hematol Oncol, Honolulu, HI 96822 USA
[8] Ohio State Univ, Columbus, OH 43210 USA
[9] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
[10] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA
[11] New York Med Coll, Dept Microbiol, Valhalla, NY 10595 USA
[12] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 159卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [31] Feasibility and efficacy of immunochemotherapy for the treatment of mature B-cell leukemia: a report from the Children's Oncology Group
    Galardy, P.
    Shiramizu, B.
    Goldman, S.
    Hochberg, J.
    Perkins, S.
    Smith, L.
    Cairo, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 44 - 44
  • [32] INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY
    Minard-Colin, V.
    Auperin, A.
    Burke, A.
    Alexander, S.
    Moreno, M.
    Buffardi, S.
    Uyttebroeck, A.
    Bollard, C.
    Zsiros, J.
    Csoka, M.
    Kazanowska, B.
    Chiang, A.
    Verschuur, A.
    Miles, R.
    Wotherspoon, A.
    Barkauskas, D.
    Wheatley, K.
    Vassal, G.
    Adamson, P.
    Gross, T.
    Patte, C.
    Pillon, M.
    LEUKEMIA RESEARCH, 2022, 121 : S43 - S43
  • [33] EFFECTIVE AND SAFE ACUTE TUMOR LYSIS SYNDROME (ATLS) PROSPHYLAXIS WITH RASBURICASE AND NON-ALKALINE HYDRATION IN CHILDREN AND ADOLESCENTS WITH ADVANCED STAGE III/IV INTERMEDIATE RISK B-CELL NON-HODGKIN LYMPHOMA (B-NHL): A CHILDREN'S ONCOLOGY GROUP REPORT
    Goldman, Stanton
    Lynch, James
    Harrison, Lauren
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 713 - 714
  • [34] A Study of Rituximab and Ifosfamide, Carboplatin, and Etoposide Chemotherapy in Children with Recurrent/Refractory B-Cell (CD20+) Non-Hodgkin Lymphoma and Mature B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
    Griffin, Timothy C.
    Weitzman, Sheila
    Weinstein, Howard
    Chang, Myron
    Cairo, Mitchell
    Hutchison, Robert
    Shiramizu, Bruce
    Wiley, Joseph
    Woods, Deborah
    Barnich, Margaret
    Gross, Thomas G.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (02) : 177 - 181
  • [35] IN CHILDHOOD B-CELL NON HODGKIN'S LYMPHOMA (B-NHL) AND MATURE B-CELL ACUTE LEUKEMIA (B-AL) WITH CNS DISEASE AT DIAGNOSIS, PATIENTS WITH BLASTS IN CSF ARE AT HIGHER RISK OF EVENT
    Minard-Colin, V.
    Auperin, A.
    Leverger, G.
    Schmitt, C.
    Aladjidi, N.
    Michon, J.
    Patte, C.
    ANNALS OF ONCOLOGY, 2011, 22 : 112 - 112
  • [36] In childhood B-cell non Hodgkin's lymphoma (B-NHL) and mature B-cell acute leukemia (B-AL) with CNS disease at diagnosis, patients with blasts in CSF are at higher risk of event
    Minard, V.
    Auperin, A.
    Leverger, G.
    Schmitt, C.
    Aladjidi, N.
    Michon, J.
    Patte, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 43 - 43
  • [37] IN CHILDHOOD B-CELL NON HODGKIN LYMPHOMA (B-NHL) AND MATURE B-CELL ACUTE LEUKEMIA (B-AL) WITH CNS DISEASE AT DIAGNOSIS, PATIENTS WITH BLASTS IN CSF ARE AT HIGHER RISK OF EVENT
    Minard-Colin, Veronique
    Auperin, Anne
    Leverger, Guy
    Schmitt, Claudine
    Aladjidi, Nadia
    Michon, Jean
    Patte, Catherine
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 978 - 979
  • [38] Efficacy of rituximab plus FAB group C chemotherapy without CNS radiation in CNS-positive pediatric Burkitt lymphoma/leukemia: A report from the Children's Oncology Group
    Frazer, J. Kimble
    Goldman, Stanton
    Smith, Lynette
    Harrison, Lauren
    Perkins, Sherrie L.
    Cairo, Mitchell S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Results of the Randomized Intergroup Trial Inter-B-NHL RITUX 2010 for Children/Adolescents with High-Risk B-Cell Non Hodgkin Lymphoma (B-NHL) and Mature Acute Leukemia (B-AL)
    Colin, V. Minard
    Auperin, A.
    Pillon, M.
    Burke, A.
    Anderson, J.
    Barkausk, D.
    Wheatley, K.
    Delgado, R.
    Alexander, S.
    Uyttebroeck, A.
    Bollard, C.
    Zsiros, J.
    Csoka, M.
    Goma, G.
    Tulard, A.
    Patte, C.
    Gross, T.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S31 - S31
  • [40] Does minimal residual disease (MRD) predict relapse in children with advance B-NHL treated with chemoimmunotherapy: a children's oncology report
    Shiramizu, B.
    Goldman, S.
    Smith, L.
    Harrison, L.
    Van de Ven, C.
    Gross, T.
    Sanger, W.
    Perkins, S.
    Cairo, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 53 - 53
12345